Least absolute shrinkage and selection operator (LASSO) regression, using variables dichotomized according to the median value of HCC patients, selected IL-13 as the only strong factor associated with HCC development in HCV patients treated using DAA, at baseline, week 4, and at the end of treatment. The gene discussed is IL13; the disease is hepatocellular carcinoma.